AlYamany, R.; Kharfan-Dabaja, M.A.; Hamadani, M.; Alshaibani, A.; Aljurf, M.
The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time. Curr. Oncol. 2022, 29, 3759-3769.
https://doi.org/10.3390/curroncol29050301
AMA Style
AlYamany R, Kharfan-Dabaja MA, Hamadani M, Alshaibani A, Aljurf M.
The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time. Current Oncology. 2022; 29(5):3759-3769.
https://doi.org/10.3390/curroncol29050301
Chicago/Turabian Style
AlYamany, Ruah, Mohamed A. Kharfan-Dabaja, Mehdi Hamadani, Alfadel Alshaibani, and Mahmoud Aljurf.
2022. "The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time" Current Oncology 29, no. 5: 3759-3769.
https://doi.org/10.3390/curroncol29050301
APA Style
AlYamany, R., Kharfan-Dabaja, M. A., Hamadani, M., Alshaibani, A., & Aljurf, M.
(2022). The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time. Current Oncology, 29(5), 3759-3769.
https://doi.org/10.3390/curroncol29050301